A Pharmacoeconomic Model for the Treatment of Influenza

This publication has 13 references indexed in Scilit:

• Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
  1998
• Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
  1998
• Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus Infections
  New England Journal of Medicine, 1997
• Economic Evaluation of Influenza Vaccination and Economic Modelling
  PharmacoEconomics, 1996
• The Impact of Three Influenza Epidemics on Primary Care in England and Wales
  PharmacoEconomics, 1996
• [Influenza: incidence and costs of inpatient treatment].
  1993
• Clinical features of influenza.
  1992
• Excess pneumonia and influenza associated hospitalization during influenza epidemics in the United States, 1970-78.
  American Journal of Public Health, 1986
• Therapeutic Effects of Aerosolized Amantadine in Naturally Acquired Infection Due to Influenza A Virus
  The Journal of Infectious Diseases, 1980
• The Swine-Influenza Decision
  New England Journal of Medicine, 1976